MF
FPRX

Magnetar Financial’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Magnetar Financial’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,406,138
Closed -$90.6M – 1516
2021
Q1 		$90.6M Buy
+2,406,138
New +$60M 0.87% 27

Magnetar Financial's FPRX Position: Q2 2021 in Review

Magnetar Financial sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 2,406,138 shares — an estimated $90.6M sold.

Magnetar Financial first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $90.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Magnetar Financial reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Magnetar Financial sold 2,406,138 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $90.6M.
  • Magnetar Financial first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Magnetar Financial's Five Prime Therapeutics, Inc. position peaked at $90.6M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Magnetar Financial's 13F filing for Q2 2021, filed 6 Aug 2021.